Salvinorin A: the 'magic mint' hallucinogen finds a molecular target in the kappa opioid receptor

被引:119
作者
Sheffler, DJ
Roth, BL
机构
[1] Case Western Reserve Univ, Sch Med, Natl Inst Mental Hlth, Psychoact Drug Screening Program, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Psychiat, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA
关键词
D O I
10.1016/S0165-6147(03)00027-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Salvinorin A, a neoclerodane diterpene, is the most potent naturally occurring hallucinogen known and rivals the synthetic hallucinogen lysergic acid diethylamide in potency. Recently, the molecular target of salvinorin A was identified as the kappa opioid receptor (KOR). Salvinorin A represents the only known non-nitrogenous KOR selective agonist. Based on the selectivity of salvinorin A for the KOR, this receptor represents a potential molecular target for the development of drugs to treat disorders characterized by alterations in perception, including schizophrenia, Alzheimer's disease and bipolar disorder.
引用
收藏
页码:107 / 109
页数:3
相关论文
共 19 条
  • [1] ABRAMOV MM, 1963, J APPL CHEM-USSR, V36, P2471
  • [2] BARD J, 1993, BRAIN RES, V632, P209
  • [3] Salvia divinorum:: an hallucinogenic mint which might become a new recreational drug in Switzerland
    Giroud, C
    Felber, F
    Augsburger, M
    Horisberger, B
    Rivier, L
    Mangin, P
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2000, 112 (2-3) : 143 - 150
  • [4] THE ABSOLUTE STEREOCHEMISTRY OF SALVINORINS
    KOREEDA, M
    BROWN, L
    VALDES, LJ
    [J]. CHEMISTRY LETTERS, 1990, (11) : 2015 - 2018
  • [5] The therapeutic role of naltrexone in negative symptom schizophrenia
    Marchesi, GF
    Santone, G
    Cotani, P
    Giordano, A
    Chelli, F
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1995, 19 (08) : 1239 - 1249
  • [6] μ-, δ- and κ-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients
    Mathieu-Kia, AM
    Fan, LQ
    Kreek, MJ
    Simon, EJ
    Hiller, JM
    [J]. BRAIN RESEARCH, 2001, 893 (1-2) : 121 - 134
  • [7] OPIOID PEPTIDE RECEPTOR STUDIES .3. INTERACTION OF OPIOID-PEPTIDES AND OTHER DRUGS WITH 4 SUBTYPES OF THE KAPPA(2) RECEPTOR IN GUINEA-PIG BRAIN
    NI, Q
    XU, H
    PARTILLA, JS
    DECOSTA, BR
    RICE, KC
    KAYAKIRI, H
    ROTHMAN, RB
    [J]. PEPTIDES, 1995, 16 (06) : 1083 - 1095
  • [8] SALVINORIN, A NEW TRANS-NEOCLERODANE DITERPENE FROM SALVIA-DIVINORUM (LABIATAE)
    ORTEGA, A
    BLOUNT, JF
    MANCHAND, PS
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1982, (10): : 2505 - 2508
  • [9] PSYCHOTOMIMESIS MEDIATED BY KAPPA-OPIATE RECEPTORS
    PFEIFFER, A
    BRANTL, V
    HERZ, A
    EMRICH, HM
    [J]. SCIENCE, 1986, 233 (4765) : 774 - 776
  • [10] Activation is hallucinogenic and antagonism is therapeutic:: Role of 5-HT2A receptors in atypical antipsychotic drug actions
    Roth, BL
    Willins, DL
    Kristiansen, K
    Kroeze, WK
    [J]. NEUROSCIENTIST, 1999, 5 (04) : 254 - 262